Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Aug;36(8):2356-8.
doi: 10.1128/JCM.36.8.2356-2358.1998.

Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing

B Toye  1 , W Woods, M Bobrowska, K Ramotar
Affiliations

Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing

B Toye et al. J Clin Microbiol. 1998 Aug.

Abstract

We determined the frequency of PCR inhibition in genital and urine specimens submitted for Chlamydia trachomatis testing using the internal control DNA provided with the COBAS AMPLICOR C. trachomatis test and assessed methods to remove it. Inhibition occurred in 65 of 906 (7%) cervical swabs, 23 of 51 (45%) urethral swabs, and 2 of 175 (1.1%) urine samples. Overall, inhibition was eliminated in processed specimens after storage at 4 degrees C in 77 of 90 specimens (86%), freezing at -70 degrees C in 59 of 82 specimens (72%), storage at 4 degrees C followed by either 1:100 dilution in 37 of 43 specimens (86%) or 1:10 dilution in 42 of 47 specimens (89%), and phenol-chloroform extraction in 79 of 80 specimens (99%). No positive specimens were missed due to inhibition. We conclude that PCR inhibition is rare with urine specimens and infrequent with endocervical swabs but occurs frequently with urethral swabs. The frequency of PCR inhibition may be significantly reduced by methods which can be easily incorporated into the processing of specimens.

PubMed Disclaimer

References

    1. Bass C A, Jungkind D L, Silverman N S, Bondi J M. Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol. 1993;31:2648–2653. - PMC - PubMed
    1. Bauwens J E, Clark A M, Stamm W E. Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. J Clin Microbiol. 1993;31:3023–3027. - PMC - PubMed
    1. Black C M. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev. 1997;10:160–184. - PMC - PubMed
    1. Chan E L, Brandt K, Antonishyn N, Horsman G B. Abstracts of the 97th General Meeting of the American Society for Microbiology. Washington, D.C: American Society for Microbiology; 1997. No inhibitory effect of male urine on Roche Amplicor for Chlamydia detection, abstr. C-391; p. 188.
    1. Chernesky M A, Chong S, Jang D, Luinstra K, Sellors J, Mahony J. Ability of commercial ligase chain reaction and PCR assays to diagnose Chlamydia trachomatis infections in men by testing first-void urine. J Clin Microbiol. 1997;35:982–984. - PMC - PubMed